• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
    • Green biotechnology
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
  • Team
    • Team
    • Collaborations
  • Insights
  • Work
    • Publications
    • Cases
  • Careers
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
    • Green biotechnology
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
  • Team
    • Team
    • Collaborations
  • Insights
  • Work
    • Publications
    • Cases
  • Careers
  • You are here:
  • Home
  • Work
  • Cases
  • Development of permissible daily exposure levels of impurities present in pharmaceutical products

Development of permissible daily exposure levels of impurities present in pharmaceutical products

ToxMinds is a key resource to a major multinational biopharmaceutical company on the safety assessment of extractables & leachables and manufacturing impurities ending up in the medicinal product.

We are working very closely with a multinational biopharmaceutical company focusing on establishing safe exposure and maximum residue levels of impurities that are present in the medicinal product unintentionally, either from the manufacturing process, the drug delivery system or the drug container; or through cross-contamination in shared manufacturing facilities. All our assessments follow a template agreed upon with our client. They are timely to avoid any market release issues, are state-of-the-art in terms of toxicology information, and in compliance with the respective ICH guidelines. For impurities for which scarce toxicological data can be identified, not permitting to derive a robust NOAEL, we typically follow new risk assessment type of approach, including QSAR modelling, analogue-based read-across assessment or the TTC approach.

More cases
  • Identification of hazards associated with non-intentionally added substances in a food contact polymer

  • Human health risk assessment of a biocidal product line for due diligence purposes

  • Feasibility screening of new molecules to be used in cosmetic applications

  • Identification of safe exposure levels of ingredients used in cosmetic and consumer products

Relevant services and sectors
  • Chemical and Product Safety

  • Regulatory Strategy and Compliance

  • Pharmaceuticals & Medical Devices

Human health risk assessment of a biocidal product line for due diligence purposes

Identification of hazards associated with non-intentionally added substances in a food contact polymer

Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BVBA
Avenue de Broqueville 116
B-1200 Brussels, Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email:

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
1015 Brigade IRV Centre, 10th Floor
Whitefield, Bangalore 560066, India

 

 
Email:

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Work
  • Careers